Human B7-H3 Monoclonal Antibody

Product Sizes

1 mg

£355.00

YR0156-1MG

5 mg

£885.00

YR0156-5MG

20 mg

£2138.00

YR0156-20MG

About this Product

SKU:: YR0156
Additional Names:: 4Ig-B7-H3, B7-H3, B7H3, B7RP-2
Application:: Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
Clonality:: Monoclonal
Extra Details:: What is ifinatamab biosimilar research grade? Ifinatamab is a humanized IgG1-kappa monoclonal antibody against the human B7-H3 (CD276) protein, a type I transmembrane protein belonging to the B7 family which includes immune checkpoint molecules CTLA-4 and PD-L1. B7-H3 is highly expressed in various types of solid tumors with low expression in normal (healthy) tissues. It was reported that B7-H3 overexpression is associated with poor prognosis in several types of cancers. Ifinatamab biosimilar uses the same protein sequences as the therapeutic antibody ifinatamab.
Formulation:: Purified from cell culture supernatant in an animal-free facility
Immunogen:: Human B7-H3
Isotype:: IgG1, kappa
Molecular Weight:: 150 kDa
Purity:: >95%
Shipping Conditions:: Blue Ice
Storage Conditions:: 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
Supplier:: ABclonal Technology
Type:: Antibody: Biosimilar Antibody

Basket